CCAR2 (cell cycle and apoptosis regulator 2) is a multifunctional nuclear protein that integrates transcriptional regulation with apoptosis and cell cycle control. As a core component of the DBIRD complex, CCAR2 regulates alternative splicing and transcript elongation at A+T-rich genomic regions 1. CCAR2 functions as a negative regulator of multiple deacetylases and histone modifiers: it inhibits SIRT1 deacetylase activity, leading to p53 acetylation and p53-mediated apoptosis 23, and negatively regulates HDAC3 deacetylase activity 4. Beyond apoptosis regulation, CCAR2 controls metabolic processes through NR1D1 and SIRT1-dependent mechanisms 56. CCAR2 exhibits dual roles in cancer: it functions as a tumor suppressor by stabilizing p53 and regulating DNA damage responses 78, yet paradoxically promotes proliferation in p53-deficient cancers by stabilizing oncogenic transcription factors 9. High CCAR2 expression correlates with poor survival in squamous cell carcinoma and neuroblastoma 10. Recent evidence suggests CCAR2 plays roles in DNA damage repair, autophagy regulation, and metabolic control through SIRT1 interactions 1112. This functional duality—simultaneously promoting apoptosis and cell survival depending on cellular context—positions CCAR2 as a master regulator of metabolism, aging, and cancer progression 13.